Skip to main content

Table 2 TRMT6 and related clinical information were statistically analyzed by Chi-square test

From: TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway

 

TRMT6 High

TRMT6 Low

p-value

Age (year)

1

 > = 50

18

18

 < 50

20

20

Gender

0.69161

 Male

34

35

 Female

4

3

BCLC stage

0.26674

 A

13

20

 B

8

4

 C

16

14

 D

1

0

Tumour-Node-Metastasis (TNM) stage

0.00006

 I

5

17

 II

15

3

 III

7

12

 IV

11

6

Primary tumor (T) classification

0.00191

 T1

5

17

 T2

20

7

 T3

8

12

 T4

5

2

Regional lymph node (N) classification

0.010701

 N0

32

38

 N1

6

0

Distant metastasis (M) classification

0.168716

 M0

27

32

 M1

11

6

Recurrence

  

0.22186

 No

10

15

 Yes

28

23

Portal vein tumor thrombus

0.236593

 No

33

31

 Yes

5

7

Microscopic tumor thrombus

0.118061

 No

25

31

 Yes

13

7